eHealth, Inc. Q1 2011 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2011. eHealth, Inc. operates as an online health insurance agency for individuals, families, and small businesses in the United States. The company generates revenue primarily through commissions from insurance carriers and, increasingly, through technology licensing and lead referral fees for Medicare-related plans. The reporting period marks the first full quarter of implementation for new federal medical loss ratio requirements, which have significantly impacted commission structures.
Key Financial Metrics
| Metric | Q1 2011 | Q1 2010 |
|---|---|---|
| Total Revenue | $37.6 million | $36.0 million |
| Net Income | $2.0 million | $3.2 million |
| Diluted EPS | $0.09 | $0.13 |
| Operating Cash Flow | $6.8 million | $3.1 million |
| Cash and Equivalents | $130.3 million | $128.1 million (Dec 31, 2010) |
| Operating Margin | 10.6% | 16.4% |
Debt and Liquidity: The company reported no bank debt or lines of credit. Total current liabilities decreased to $15.6 million from $20.2 million in the prior year. Stockholders' equity remained stable at approximately $162.8 million.
Material Changes vs. Prior Period
- Revenue Mix Shift: While total revenue increased 4%, Commission revenue declined 3% to $30.8 million due to reduced commission rates mandated by new medical loss ratio regulations. Conversely, Other revenue (technology licensing and Medicare leads) surged 61% to $6.8 million.
- Profitability Decline: Net income dropped 39% year-over-year. Operating income fell from $5.9 million to $4.0 million, driven by lower commission rates and increased operating costs.
- Expense Increases:
- Cost of Revenue: Increased 171% to $2.7 million, primarily due to government systems activities and revenue-sharing costs.
- Customer Care: Rose 37% to $5.4 million due to the full-year impact of a new Salt Lake City call center for Medicare services.
- Technology: Increased 19% to $5.5 million due to headcount growth and data center investments.
- Marketing Efficiency: Marketing and advertising expenses decreased 13% to $12.9 million as the company strategically reduced spending on individual and family plans in response to lower commission returns.
- Membership Growth: Total estimated membership grew 6% to 801,200, though approved members for individual and family plans decreased 11% due to reduced marketing spend.
Outlook, Risks, and Management Commentary
- Guidance: Management expects commission revenue to decrease in absolute dollars and as a percentage of total revenue for the full year 2011. They anticipate "Other revenue" will increase as a percentage of total revenue. Earnings per share are expected to be substantially lower in 2011 compared to 2010.
- Regulatory Impact: The implementation of the Affordable Care Act's medical loss ratio requirements has forced carriers to reduce commission rates on individual and family plans. Management estimates the average base commission rate for these plans dropped from just over 10% to just below 7%.
- Strategic Pivot: The company is shifting focus toward Medicare-related plans (Advantage, Supplement, Part D) and technology licensing for government exchanges to offset declines in traditional individual/family commission revenue.
- Stock Repurchase: The company completed a $30 million stock repurchase program in January 2011, acquiring approximately 2.3 million shares.
- Risks: Key risks include the potential for further commission rate reductions, the success of the new Medicare business model, reliance on a limited number of lead purchasers for Medicare referrals, and the impact of health care reform on the broader insurance market.
Investor Verification Checklist
- Verify the sustainability of the 61% growth in "Other revenue" (Medicare leads and licensing) to ensure it can offset the structural decline in commission revenue.
- Monitor the conversion rates and retention of the new Medicare customer base, as this segment is highly seasonal and dependent on annual enrollment periods.
- Assess the impact of the 11% decline in approved individual and family members on long-term recurring revenue streams.
- Review the concentration risk regarding Medicare lead purchasers, as the filing notes dependence on a limited number of buyers for this revenue stream.
- Track the effectiveness of cost-cutting measures in marketing and advertising to ensure they do not disproportionately harm future member acquisition.